-
Innovation Ranking
NewInnovation Ranking – Legend Holdings Corp
Legend Holdings Corp (Legend Holdings) is an investment holding company that makes strategic and financial investments with the aim to generate returns. The company has investments in financial service, innovative consumption, agriculture, food, information technology, advanced manufacturing, and professional services sectors. Legend Holding’s strategic investments focus on long-term returns and on strategic sectors to optimize its portfolio. Through its financial investments, the company focuses on investment opportunities in all development phases of the enterprise and includes angel investment, private equity...
-
Product Insights
NewNet Present Value Model: Legend Biotech Corp’s LB-1908
Empower your strategies with our Net Present Value Model: Legend Biotech Corp's LB-1908 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Onureg in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onureg in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onureg in Chronic Lymphocytic Leukemia (CLL) Drug Details: Azacitidine (Onureg)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ciltacabtagene Autoleucel in Multiple Myeloma (Kahler Disease) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LCAR-G08 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LCAR-G08 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LCAR-G08 in Pancreatic Cancer Drug Details: LCAR-G08 is under development for...
-
Analyst Opinions
Snacks Demand Spaces and Top Trends
Snacks Demand Spaces and Top Trends Report Overview The concept of "demand spaces" has gained popularity among brands across the FMCG spectrum. Demand spaces are an iteration of the longstanding analytical mode based around the "five Ws:" the who, what, when, where, and whys of consumer attitudes and behaviors. These spaces are manifestations of different combinations of these factors that describe consumption occasions with audiences, product choices, purposes, locations, and so on. Overlaying distinctive demand spaces for each category onto...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Gastric Cancer Drug Details: LB-1908 (LCAR-C18S) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Esophageal Cancer Drug Details: LB-1908 (LCAR-C18S) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Metastatic Adenocarcinoma of The Pancreas Drug Details:...